vs

Side-by-side financial comparison of Shoals Technologies Group, Inc. (SHLS) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.

Shoals Technologies Group, Inc. is the larger business by last-quarter revenue ($148.3M vs $76.2M, roughly 1.9× VIEMED HEALTHCARE, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs 5.5%, a 1.9% gap on every dollar of revenue. On growth, Shoals Technologies Group, Inc. posted the faster year-over-year revenue change (38.6% vs 25.5%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $-11.3M). Over the past eight quarters, Shoals Technologies Group, Inc.'s revenue compounded faster (27.8% CAGR vs 22.7%).

Shoals Technologies Group is a leading provider of electrical balance of systems solutions for renewable energy and e-mobility. It supplies connectivity components for solar projects, energy storage systems and EV charging infrastructure, serving clients across North America, Europe and Asia-Pacific.

Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.

SHLS vs VMD — Head-to-Head

Bigger by revenue
SHLS
SHLS
1.9× larger
SHLS
$148.3M
$76.2M
VMD
Growing faster (revenue YoY)
SHLS
SHLS
+13.1% gap
SHLS
38.6%
25.5%
VMD
Higher net margin
VMD
VMD
1.9% more per $
VMD
7.4%
5.5%
SHLS
More free cash flow
VMD
VMD
$21.0M more FCF
VMD
$9.7M
$-11.3M
SHLS
Faster 2-yr revenue CAGR
SHLS
SHLS
Annualised
SHLS
27.8%
22.7%
VMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SHLS
SHLS
VMD
VMD
Revenue
$148.3M
$76.2M
Net Profit
$8.1M
$5.6M
Gross Margin
31.6%
57.9%
Operating Margin
11.7%
11.0%
Net Margin
5.5%
7.4%
Revenue YoY
38.6%
25.5%
Net Profit YoY
3.9%
30.7%
EPS (diluted)
$0.05
$0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SHLS
SHLS
VMD
VMD
Q4 25
$148.3M
$76.2M
Q3 25
$135.8M
$71.9M
Q2 25
$110.8M
$63.1M
Q1 25
$80.4M
$59.1M
Q4 24
$107.0M
$60.7M
Q3 24
$102.2M
$58.0M
Q2 24
$99.2M
$55.0M
Q1 24
$90.8M
$50.6M
Net Profit
SHLS
SHLS
VMD
VMD
Q4 25
$8.1M
$5.6M
Q3 25
$11.9M
$3.5M
Q2 25
$13.9M
$3.2M
Q1 25
$-282.0K
$2.6M
Q4 24
$7.8M
$4.3M
Q3 24
$-267.0K
$3.9M
Q2 24
$11.8M
$1.5M
Q1 24
$4.8M
$1.6M
Gross Margin
SHLS
SHLS
VMD
VMD
Q4 25
31.6%
57.9%
Q3 25
37.0%
57.5%
Q2 25
37.2%
58.3%
Q1 25
35.0%
56.3%
Q4 24
37.6%
59.5%
Q3 24
24.8%
59.3%
Q2 24
40.3%
59.8%
Q1 24
40.2%
58.9%
Operating Margin
SHLS
SHLS
VMD
VMD
Q4 25
11.7%
11.0%
Q3 25
13.7%
7.8%
Q2 25
14.4%
8.1%
Q1 25
5.4%
6.5%
Q4 24
15.4%
10.6%
Q3 24
4.4%
9.7%
Q2 24
18.7%
6.6%
Q1 24
12.8%
4.4%
Net Margin
SHLS
SHLS
VMD
VMD
Q4 25
5.5%
7.4%
Q3 25
8.7%
4.9%
Q2 25
12.5%
5.0%
Q1 25
-0.4%
4.4%
Q4 24
7.3%
7.1%
Q3 24
-0.3%
6.7%
Q2 24
11.9%
2.7%
Q1 24
5.3%
3.2%
EPS (diluted)
SHLS
SHLS
VMD
VMD
Q4 25
$0.05
$0.14
Q3 25
$0.07
$0.09
Q2 25
$0.08
$0.08
Q1 25
$0.00
$0.06
Q4 24
$0.04
$0.10
Q3 24
$0.00
$0.10
Q2 24
$0.07
$0.04
Q1 24
$0.03
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SHLS
SHLS
VMD
VMD
Cash + ST InvestmentsLiquidity on hand
$7.3M
$13.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$600.0M
$141.5M
Total Assets
$904.1M
$199.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SHLS
SHLS
VMD
VMD
Q4 25
$7.3M
$13.5M
Q3 25
$8.6M
$11.1M
Q2 25
$4.7M
$20.0M
Q1 25
$35.6M
$10.2M
Q4 24
$23.5M
$17.5M
Q3 24
$11.1M
$11.3M
Q2 24
$3.2M
$8.8M
Q1 24
$15.2M
$7.3M
Total Debt
SHLS
SHLS
VMD
VMD
Q4 25
Q3 25
Q2 25
Q1 25
$141.8M
Q4 24
$141.8M
Q3 24
$141.8M
Q2 24
$146.8M
Q1 24
$168.8M
Stockholders' Equity
SHLS
SHLS
VMD
VMD
Q4 25
$600.0M
$141.5M
Q3 25
$589.6M
$133.6M
Q2 25
$575.4M
$139.7M
Q1 25
$558.9M
$134.8M
Q4 24
$556.8M
$131.4M
Q3 24
$545.2M
$125.0M
Q2 24
$544.6M
$119.4M
Q1 24
$554.0M
$116.3M
Total Assets
SHLS
SHLS
VMD
VMD
Q4 25
$904.1M
$199.2M
Q3 25
$851.8M
$202.4M
Q2 25
$795.0M
$184.6M
Q1 25
$788.4M
$178.1M
Q4 24
$793.1M
$177.1M
Q3 24
$801.3M
$169.5M
Q2 24
$788.4M
$163.9M
Q1 24
$825.3M
$154.9M
Debt / Equity
SHLS
SHLS
VMD
VMD
Q4 25
Q3 25
Q2 25
Q1 25
0.25×
Q4 24
0.25×
Q3 24
0.26×
Q2 24
0.27×
Q1 24
0.30×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SHLS
SHLS
VMD
VMD
Operating Cash FlowLast quarter
$-4.1M
$18.4M
Free Cash FlowOCF − Capex
$-11.3M
$9.7M
FCF MarginFCF / Revenue
-7.6%
12.7%
Capex IntensityCapex / Revenue
4.8%
11.5%
Cash ConversionOCF / Net Profit
-0.50×
3.27×
TTM Free Cash FlowTrailing 4 quarters
$-16.0M
$11.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SHLS
SHLS
VMD
VMD
Q4 25
$-4.1M
$18.4M
Q3 25
$19.4M
$18.4M
Q2 25
$-13.8M
$12.3M
Q1 25
$15.6M
$2.9M
Q4 24
$14.0M
$15.0M
Q3 24
$15.7M
$12.7M
Q2 24
$37.8M
$10.2M
Q1 24
$12.9M
$1.2M
Free Cash Flow
SHLS
SHLS
VMD
VMD
Q4 25
$-11.3M
$9.7M
Q3 25
$9.0M
$10.7M
Q2 25
$-26.0M
$4.1M
Q1 25
$12.3M
$-12.6M
Q4 24
$12.5M
$3.2M
Q3 24
$13.3M
$1.7M
Q2 24
$35.8M
$1.2M
Q1 24
$10.4M
$-4.8M
FCF Margin
SHLS
SHLS
VMD
VMD
Q4 25
-7.6%
12.7%
Q3 25
6.6%
14.9%
Q2 25
-23.5%
6.5%
Q1 25
15.4%
-21.4%
Q4 24
11.6%
5.2%
Q3 24
13.0%
3.0%
Q2 24
36.1%
2.3%
Q1 24
11.4%
-9.5%
Capex Intensity
SHLS
SHLS
VMD
VMD
Q4 25
4.8%
11.5%
Q3 25
7.7%
10.6%
Q2 25
11.0%
12.9%
Q1 25
4.0%
26.2%
Q4 24
1.4%
19.5%
Q3 24
2.3%
19.0%
Q2 24
2.0%
16.3%
Q1 24
2.7%
11.9%
Cash Conversion
SHLS
SHLS
VMD
VMD
Q4 25
-0.50×
3.27×
Q3 25
1.63×
5.23×
Q2 25
-1.00×
3.88×
Q1 25
1.09×
Q4 24
1.79×
3.47×
Q3 24
3.29×
Q2 24
3.21×
6.94×
Q1 24
2.69×
0.73×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SHLS
SHLS

System Solutions$122.0M82%
Components$26.3M18%

VMD
VMD

Segment breakdown not available.

Related Comparisons